Arthroscopic guided synovial biopsies by Orr, Carl Kieran et al.
MINI REVIEW
published: 11 February 2021
doi: 10.3389/fmed.2020.604582







Hospital Clínic de Barcelona, Spain
Stefano Alivernini,





†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Rheumatology,
a section of the journal
Frontiers in Medicine
Received: 09 September 2020
Accepted: 23 November 2020
Published: 11 February 2021
Citation:
Orr CK, Vieira-Sousa E, Fonseca JE






Carl Kieran Orr 1*†, Elsa Vieira-Sousa 2,3†, João Eurico Fonseca 2,3 and Douglas Veale 1
1Centre for Arthritis and Rheumatic Diseases, Saint Vincent’s University Hospital, University College Dublin, Dublin, Ireland,
2 Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic
Medical Center, Lisbon, Portugal, 3 Rheumatology Research Unit, Faculdade de Medicina, Instituto de Medicina Molecular
João Lobo Antunes, Universidade de Lisboa, Lisbon, Portugal
Synovial tissue can be safely and reliably collected for research and clinical purposes
using arthroscopy. This technique offers the obvious advantage of allowing direct
visualization, and targeted biopsy of specific areas of interest within the joint, as well as for
the collection of tissue which will include a lining layer. Much has been learnt by studying
the synovium retrieved using this technique concerning the pathobiology of inflammatory
arthritis. Furthermore, recent evidence suggests that the tissue retrieved may enable the
identification of unique pathotypes that will allow for a precise approach to treatment
selection in individual patients. Although ultrasound guided techniques for sampling
synovial tissue have gained in popularity over the last decade, both methodologies
are expected to compliment each other, each having unique benefits and drawbacks.
We present here a detailed description of the arthroscopy technique reporting on our
collective experience at two centers in Europe.
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INTRODUCTION
The synovium is the primary target tissue in inflammatory arthritis (IA), and it therefore follows
that analysis of this tissue must yield important clues to advance our understanding of the
underlying pathobiology of these heterogenous diseases. The field has rapidly expanded over the
last three decades, and this has led to some very significant developments in unraveling the cellular
andmolecular networks underlying the development and perpetuation of IA (1–4). Putative targets
have been identified by synovial tissue (ST) analysis (5). ST has been used in the evaluation of
current and potential treatments, in both in vivo and ex vivo settings (6, 7). Recent evidence
suggests that it may be possible to stratify patients with rheumatoid arthritis (RA) on the basis
of histopathology and transcriptomic analysis, into groups with differing underlying pathobiology,
and with differential responses to therapies (8–10). These developments have depended on the
ability to reliably retrieve ST, in a safe manner, and in such a way as to be well-tolerated
by patients. Although much data has been published on tissue retrieved at arthroplasty, the
suitability and applicability of these findings to IA at much earlier timepoints in the disease course
remains unclear. Therefore, arthroscopy was adopted by Rheumatologists to allow ST sampling
at varying points in the disease course and has long been the favored technique historically.
This technique has the advantage of providing direct intra-articular visualization of synovium
as well as a therapeutic joint lavage. Both synovial membrane proliferation and vascularization
patterns have been described. Certain vascular patterns, although not diagnostic, can be suggestive
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of some subtypes of inflammatory arthritis (straight versus
tortuous pattern) which can be of particular interest in early and
undifferentiated arthritis. Furthermore, crystal deposits, cartilage
damage, chondromas and other intra-articular pathologies can
be identified contributing for the differential diagnosis of
synovitis (11, 12). Sonographically guided techniques have been
developed and refined more recently, and it is likely that
these techniques will complement ST retrieved under direct
arthroscopic guidance. In this review, we describe the general
aspects of the technique of arthroscopic guided synovial biopsies
(AGSB) of the knee joint under local anesthetic, as performed
in two European Rheumatology Centers: St. Vincent’s University
Hospital, Dublin and Hospital de Santa Maria, Lisbon.
PATIENT RECRUITMENT AND INDICATION
FOR AGSB
The authors of this review (CO, EV-S, DV) have experience
performing AGSB for patients recruited at the Inflammatory
Arthritis Clinics at St. Vincent’s University Hospital in Dublin,
and from the dedicated Mini-arthroscopy Clinic at Hospital
de Santa Maria in Lisbon. Patients are referred either with
undifferentiated arthritis or an arthritis flare of an established
IA for potential sampling, for diagnostic and/or therapeutic
purposes. The specific organization of these clinics allows for
enrichment for recruitment, and all medical staff at each center
are made aware of the clinical benefits and research programs,
and they contribute to patient recruitment. These arthroscopy
clinics are focused solely on knee arthritis, and patients with
swollen and painful knees are referred.
Knee arthroscopies are performed on patients with a wide
range of diagnoses or potential diagnoses: most commonly
this is rheumatoid arthritis (RA), undifferentiated arthritis,
or spondylarthritis. Furthermore, we have found that most
patients are willing to consent to a second arthroscopy and are
often less apprehensive about this, having already experienced
the procedure (13). This commonly occurs when a treatment
change is indicated following arthroscopy, in which circumstance
patients are invited to return for follow up ST sampling 12
weeks later.
ETHICS AND CONSENT
The patient is given written information in the form of a Patient
Information Leaflet (PIL) that contains relevant information
regarding the procedure, the potential risks and instructions
post-procedure. For example, patients are instructed not to drive
immediately after the arthroscopy, and to rest for the first 48 h.
The consent form and the PIL are provided to the patient at the
time of recruitment. Local Ethics Committees approve all studies,
including the procedure itself where this is conducted exclusively
for research purposed. Patient confidentiality is a priority and no
identifiable data is retained. If agreeable, patients are scheduled
to attend for arthroscopy at the next available slot. We endeavor
to ensure that this is within 2 weeks, in order to provide timely
access to diagnosis, therapeutic benefit and treatment initiation
or change.
On the morning of arthroscopy, patients are requested to
bring their PIL/informed consent and there is further discussion
with the physician performing the procedure, and an opportunity
for any questions to be answered. The patients are invited to
consent to the procedure itself, the collection and retention of
synovial tissue and blood for research purposes, as well as the
collection and anonymous storage of particular demographic
data and disease features.
PATIENT DATA
Relevant demographic and disease specific data including
ongoing medication, disease activity (e.g., tender and swollen
joint counts, patient global health evaluation) as well as validated
patient reported outcomes such as the SF-36 and HAQ, as
well as the indication for the procedure, are captured. On the
morning of the procedure, patients are told to have a light
breakfast, and on arrival, the completed forms are checked, and a
comprehensive clinical examination is performed and recorded,
including various disease activity measurements.
PRE-PROCEDURE ASSESSMENT
A detailed patient’s medical history is collected and a plain
film radiograph of the knee is requested (if not available) as
well as laboratorial evaluation including coagulation parameters.
For example, antiaggregant such as clopidogrel and direct
oral anti-coagulants or warfarin, are contraindicated unless
these can safely be discontinued for an appropriate time
before the procedure or occasionally replaced by low molecular
weight heparin.
PROCEDURE
Arthroscopies are performed in a dedicated, facility, within
the hospital’s Clinical Research Center (Dublin) and within
the Rheumatolgy Technical Procedures Unit (Lisbon). The unit
comprises an anteroom and a procedure room. Patient’s change
into hospital gowns in the anteroom and usually an intravenous
cannula is sited. Cannulation facilitates phlebotomy, for both
research bloods and the hospital laboratory to process relevant
hematological and biochemical indices. The knee that is to be the
site of sampling is marked with a skin marker.
We start by switching the arthroscopy tower on, and by
ensuring that both the camera and the light source are working.
Patient’s hospital identification and knee laterality is inserted for
image capture. At both centers, Karl Storz, Germany, equipment
are used. In Dublin a 2.7mm needle arthroscope is used and
in Lisbon a 2.7mm Hopkins II, 30◦ telescope. The operator
scrubs and gowns using standard techniques described elsewhere
(14). A theater nurse assists the operator before and throughout
the procedure but does not scrub, respecting well-defined
aseptic areas.
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FIGURE 1 | Arthroscopy equipment.
All surgical instruments and the Karl Storz hardware kit
which contain arthroscopy telescope, trocars, forceps, are
assembled in sterile packs and opened on a sterile draped
table. In addition, sterile gauzes, syringes, needles, infusion
system, sterile bowls and sterile drapes are opened by the
theater nurse, received by the operator, and placed on the
table. Chlorhexidine and sterile water are poured by the nurse
into the sterile bowls on the table. A 20ml syringe is filled
with lignocaine 2%, and another 20ml syringe filled with
bupivacaine 0.5% (Dublin). The local anesthetic products and
expiry dates are checked by both the nurse and the operator.
Figure 1 depicts the prepared equipment assembled on a
sterile trolley.
Before proceeding any further, a deliberate pause is
undertaken to complete a reviewed “WHO Surgical Safety
Checklist” for this procedure. Amongst the most important
items on the list are a check that we have the correct patient,
that the correct knee has been labeled, and that equipment has
been arranged for this knee to be biopsied, as well as a final
check to confirm the consent form has been completed, and
that the patient is not on anti-coagulants/anti-aggregants, and
an allergy check. Throughout the procedure we pay careful
attention to the patient’s comfort and explain each step as
we proceed.
A disposable sterile sheet is placed under the lower limb and
the leg is raised to 45◦, with the assistance of the nurse who holds
the patient’s heel up. Sterile gauze is held in a pair of forceps and
soaked in Chlorexidine. The knee is sterilized by swabbing in ever
widening circles from the lateral aspect of the knee, where the two
small incisions will be made. The area frommid-thigh tomid-calf
is disinfected circumferentially.
In Dublin, a bespoke sterile sleeve closed at one end is placed
over the foot and extended the length of the leg with care taken
not to contaminate the cleaned field. The leg is next inserted
through the fenestration in a sterile drape and the drape advanced
to the hip. The two corners of the drape closest to the cephalic
end are risen and attached to drip stands either side of the bed.
This occludes the patient from inadvertently touching the sterile
field. A sterile gauze bandage is applied circumferentially around
ankle (which is covered by the sleeve). A window large enough
to access the antero-lateral aspect of the knee is cut out of the
sterile sleeve using a pair of scissors, taking care not to injure
the skin. A similar setup with minor differences is performed
in Lisbon.
The anatomical landmarks must now be identified. The knee
is placed in 30–45 degrees flexion. Following palpation, a tissue
marker can be used to delineate the lateral border of the
infrapatellar tendon, the infero-lateral aspect of the patella, the
anterolateral border of the tibial plateau, and the infero-lateral
surface of the lateral epicondyle. The center of these markings
is the site of entry for infero-lateral port. The landmark for the
supero-lateral port is 1 cm above and 1 cm lateral to the supero-
lateral aspect of the patella, the site used commonly for intra-
articular injections. The joint capsule, soft tissues and skin is
infiltrated with 10ml of lignocaine 2%, for what will become the
superior-lateral port site and the inferior-lateral port site. About
2–5min is given to allow for this to take effect. Arthrocentesis
is performed using a 21G needle, attached to an empty 10/20ml
syringe through the site of the prospective supero-lateral port and
synovial fluid is drained until no further fluid can be removed.
Obtaining synovial fluid at this point gives high assurance that
the tip of the needle is indeed in the joint cavity. Any synovial
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fluid removed is carefully placed on the sterile drape covered
table. If no fluid can be removed, special care must be taken in
the next steps.
The needle is left in situ while the syringe is detached. The
20ml bupivacaine containing syringe is attached to the needle.
There should be little or no resistance to the plunger advancing. If
the operator encounters resistance, especially where no synovial
fluid was obtained, the needle may be misplaced and may require
adjustment. After placement of the bupivacaine into the joint
cavity, the needle is left in situ and a further 2–5min is given to
allow the bupivacaine to take effect.
A sterile sleeve covers the camera wire and camera head, and
the sterilized wire light source is attached to the camera. An
infusion system attached to a saline solution is also connected
to the telescope trocar. The white balance is ensured by placing a
gauze in front of the lens.
In Dublin in the next step, the empty syringe is detached
from the needle and the 50ml syringe containing sterile water
is attached to the needle. The contents of the syringe are placed
into the joint until resistance is felt. Typically, a joint will
accommodate up to 60ml more fluid.
With the knee in a 30–45 degree flexed position, a scalpel is
used to make a 1 cm incision in the infra-lateral patella space
previously delineated, extending to the joint capsule. The trocar
is introduced through the incision using blunt dissection into the
joint cavity. It is imperative not to force the trocar if resistance
is met. Once in situ, the trocar is removed, leaving the port in
position, and the rigid camera is inserted through the infero-
lateral port.
The cavity of the knee joint can now be inspected. It
is important to make certain that the arthroscopy is being
video recorded and that photographs are taken. We inspect
all visually accessible areas and arbitrarily divide the joint
into discrete compartments, as occasionally synovitis can be
quite focal. We record synovitis and vascularity scores as
appraised by the operator on visual analog scales ranging from
0 to 100mm (Dublin) or a 0 to 3 severity scale (Lisbon).
There have been attempts to develop a reliable scoring system
for synovitis observed at arthroscopy, but until recently the
numbers studied were small and no system has been validated
(15). Our data suggests that there is a correlation between
macroscopic synovitis scores and C reactive protein, histological
inflammation and the development of erosions (16). More
recently, a comprehensive scoring system has been proposed
called the “Macro-score,” and has been shown to exhibit excellent
inter- and intra-rater variation (17). We also record the pattern
of vascularity which has been shown to differ between, for
example RA and psoriatic arthritis (11, 18). Figure 2 depicts
exemplar images for synovitis and vascularity. Other notable
findings are also recorded, such as synovial crystal deposits,
tophi or any other intra-articular pathologies. The under-surface
of the patella is inspected, and any chondropathy observed
is recorded.
To establish the second port required to allow AGSB, the
camera is placed such that it points toward to area where the
superior-lateral port will be positioned. This can be found by
using a finger to exert pressure over the site, and the operator can
FIGURE 2 | (A) Macroscopic aspects of synovitis with villi formation and (B)
synovium vascularization.
FIGURE 3 | Ilustrative images of arthroscopy procedure.
see the depression made by this action within the joint on screen.
Once again, a scalpel is used to make a 1 cm incision extending to
the joint capsule and then blunt dissection using a trocar allows
the second port be sited.
Sterile saline via a drip is connected to the camera port,
and a drain connected to the grasper port with tubing to a
basin or collection bag. A rigid grasper is inserted through the
supero-lateral port and synovial biopsies can be collected under
direct visualization. Figure 3 illustrates the positioning of the
ports and their relationship to the other equipment discussed
above. For time optimization, when diffuse synovitis is present
biopsies can be easily performed without direct visualization. The
biopsies are placed on saline soaked gauze. When all biopsies
have been taken, they are immediately collected to minimize
delay in processing.
We check for any bleeding after biopsy collection and
complete an effective joint lavage-usually approximately 1,500ml
thought the procedure. The superolateral trocar is removed after
draining all the fluid from the joint.
Whenever indicated, intra-articular corticosteroids, are
administrated. This is followed by the administration of
8ml of bupivacaine is intra-articular to allow a sustained
anesthetic benefit (Lisbon). The infrapatellar port (and camera)
is removed. The two port sites are wiped clean, and either
paper stitches or a single stich at each portal are applied to
each incision. We next apply a small square dressing to each
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incision and apply a waterproof patch. Now the sterile drapes
and sleeve are removed, and the knee is wrapped firstly with a
cotton wool bandage (Dublin) and then with a crepe bandage
(Dublin and Lisbon).
POST-PROCEDURE ASSESSMENT
A procedure note is recorded which includes synovitis and
vascularity scores, blood vessel pattern, chondropathy,
crystal deposits if present, and whether intra-articular
steroids were administered as well as the amount of
saline used during the arthroscopy. We have developed
a proforma to make this faster and to standardize the
procedure notes.
The patient is given written information concerning post
procedural care. They are told to remove the crepe and cotton
wool bandage after 12–24 h, a waterproof cover is useful to
keep the knee dry for 3 days, and to remove the dressing
and paper (Dublin) or surgical stitches (Lisbon) in 7 days.
They are told to rest, and not to drive for 48 h. If they have
persistent swelling we ask them to apply ice. Patients are given
emergency contact details for the Rheumatology department, and
are given an outpatient appointment for 1 week or 2 weeks’
time, when the wounds are inspected, the results from synovial
fluid/synovial membrane verified and any indicated change to
treatment is implemented.
SAFETY AND TOLERABILITY
Overall safety and tolerability of AGSB in the hands of
rheumatologists is reflected in several publications including
those from our groups in Dublin and from integrated
data from Lisbon in an international study recently
published by Just et al. (13, 19). We quote our patients for
adverse events related to the procedure such as persistent




AGSB performed by Rheumatologists is associated with
diagnostic and therapeutic benefits. Collecting the tissue allows
for appropriate histologic and microbiologic evaluation of
the synovial membrane, but additionally AGSB allows for
the direct visualization of intra-articular space as well as
facilitating an efficacious joint lavage. Additionally, intra-
articular corticosteroids and/or anesthetics can be administered
with symptomatic relief. Remarkably, 66.9% (91/136) of our
patients felt improvement in their knee symptoms within 2 weeks
of arthroscopy (20). Some factors which may explain this include
the removal of inflammatory synovial fluid, the knee lavage itself,
and the intraarticular injection of corticosteroids in a minority
of the patients surveyed. Although few comparative studies have
been published, arthroscopic joint lavage plus intra-articular
corticosteroids injection is superior to intra-articular injection of
corticosteroid alone following joint aspiration in a randomized
clinical trial (21).
CHALLENGES
It is widely accepted that AGSB requires technical skills
and dedicated training for the operator, which is currently
restricted to a small number of academic centers. In addition
to this challenge, international guidelines standardizing AGSB as
performed by rheumatologists, are scarce (22). As noted by Smits
et al., it is certain that ongoing performance of the procedure
is important in maintaining skills, which can be appraised by
examining biopsy yield and quality, as well as safety record, but
it is not known how many supervised procedures are required
to attain competency, and how frequently procedures should be
performed to maintain this competency, and these factors might
be operator dependent (23).
Humby et al. has reviewed the pros and cons of the
various methodologies for biopsying synovium (24). The
preferred method will likely depend on the clinical or
research question being addressed, and in particular, whether
lining layer is essential, and how much tissue is required.
The obvious benefit of arthroscopy for ST collection is the
reliable, relatively large quantity of material retrieved, and
the ability to target of areas of most significant synovitis
within the joint under direct visualization, as well as reliably
collecting lining layer. One limitation of AGSB is its general
restriction to large joints. However, there is some evidence
to suggest that tissue retrieved from an inflamed knee
joint is similar to that obtained contemporaneously from an
inflamed wrist or metacarpophalangeal joint (25). Furthermore,
in subjects with clinically evident disease manifest in small
joints, similar histological abnormalities have been recorded
in apparently clinically uninvolved knee joints (26, 27).
Taken together, these findings would suggest that AGSB of
a large joint, should be representative tissue for studying IA
from a histologic perspective. Joint specific synovial fibroblast
phenotypes have also been described owing to anatomical
transcriptional diversity, and this may have implications for
the wider applicability of sampling from any given single
joint (28). Of interest, recent evidence suggests that DNA
methylation and transcriptome signatures in RA fibroblast-
like synoviocytes can vary between knees and hips for
example, but the clinical implications for diagnostic or
therapeutic decisions in clinical practice from this data is still
limited (29).
Additionally, non-swollen joints can also be biopsied with
success such as those from patients with osteoarthritis or after
successful treatment inflammatory arthritis.
CONCLUSION
AGSB as performed by rheumatologists is a safe and reliable
technique for sampling synovial tissue that is most suited
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to large joints. It has been the preferred “gold-standard”
method, and for the last decade the cornerstone for the
development of newer synovial tissue biopsy techniques,
namely sonographically guided. It is hoped that the
addition of these tools may broaden the accessibility of
using synovial biopsies in research and clinical settings
in the Rheumatology field. Arthroscopy will however
undoubtedly remain an important tool in investigating IA
with complementary therapeutic benefits, and specifically
identifying synovial biomarkers that will allow the page to
be turned toward precision medicine for our patients with
heterogenous IA.
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